2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Laryngeal Cancer
Laryngeal cancer, affecting the voice box, is a significant focus of cancer research aimed at understanding its causes, improving early detection, and refining treatment options. Researchers explore risk factors such as smoking, alcohol consumption, and exposure to certain chemicals. They investigate genetic predispositions and the role of viruses like HPV. Early diagnosis methods like imaging and biomarker tests are under scrutiny to enhance detection accuracy and timeliness. Treatment advancements include targeted therapies, immunotherapy, and precision surgery to preserve laryngeal function. Clinical trials assess novel interventions to improve patient outcomes and quality of life. Interdisciplinary collaboration drives progress, aiming for personalized approaches that address the complexities of laryngeal cancer while minimizing its impact.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China